PHAM QUANG X

PrivateCIK: 1405290
Location

MISSION VIEJO, CA

Senior insider sale

CEO and Chairman at CADRENAL THERAPEUTICS, INC. — senior position signals high conviction

$414.9K

99.71K shares

What this filing means

PHAM QUANG X plans to sell 99.71K shares of CADRENAL THERAPEUTICS, INC. valued at approximately $414.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.

InsiderPHAM QUANG XCIK 1405290
DirectorOfficer10% Owner· CEO and Chairman
Since Jan 2023
99.71K
Shares to sell
$414.9K
Approx. market value
40K
Acquired (3 months)
1
Planned
14 completed
Securities Acquired — Last 3 Months1
Sort

Founders Shares

N/A

1/25/2022
40K
Total acquired40K
Planned & Completed Dispositions15
Sort

Completed

Completed

Units to sell

13K

Market value

$51.2K

6/12/2026
Completed

Units to sell

1.46K

Market value

$6.0K

6/11/2026
Completed

Units to sell

3.50K

Market value

$14.7K

6/10/2026
Completed

Units to sell

12.99K

Market value

$53.3K

6/9/2026
Completed

Units to sell

5.89K

Market value

$25.8K

6/8/2026
Completed

Units to sell

2.06K

Market value

$9.1K

6/5/2026
Completed

Units to sell

3.90K

Market value

$17.2K

6/4/2026
Completed

Units to sell

2.32K

Market value

$9.9K

6/3/2026
Completed

Units to sell

349.00

Market value

$1.6K

6/2/2026
Completed

Units to sell

303.00

Market value

$1.5K

5/29/2026
Completed

Units to sell

2.99K

Market value

$14.7K

5/28/2026
Completed

Units to sell

1.17K

Market value

$6.6K

5/22/2026
Completed

Units to sell

3.30K

Market value

$17.4K

5/12/2026
Completed

Units to sell

6.48K

Market value

$37.3K

5/11/2026

Planned — Approximate Date

NASDAQPlanned

Units to sell

40K

Market value

$148.4K

6/15/2026
Total

Units

99.71K

Value

$414.9K

PHAM QUANG X — Planned Insider Sale (Form 144) | Finecho